GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Doxa AB (OSTO:DOXA) » Definitions » EV-to-EBIT

Doxa AB (OSTO:DOXA) EV-to-EBIT : 167.10 (As of May. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Doxa AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Doxa AB's Enterprise Value is kr1,554.01 Mil. Doxa AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr9.30 Mil. Therefore, Doxa AB's EV-to-EBIT for today is 167.10.

The historical rank and industry rank for Doxa AB's EV-to-EBIT or its related term are showing as below:

OSTO:DOXA' s EV-to-EBIT Range Over the Past 10 Years
Min: -125.54   Med: -5.4   Max: 191.59
Current: 167.1

During the past 13 years, the highest EV-to-EBIT of Doxa AB was 191.59. The lowest was -125.54. And the median was -5.40.

OSTO:DOXA's EV-to-EBIT is ranked worse than
96.29% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs OSTO:DOXA: 167.10

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Doxa AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr1,755.98 Mil. Doxa AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr9.30 Mil. Doxa AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.53%.


Doxa AB EV-to-EBIT Historical Data

The historical data trend for Doxa AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doxa AB EV-to-EBIT Chart

Doxa AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.78 -9.51 36.31 -34.65 6.28

Doxa AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.58 23.41 1.95 6.28 188.82

Competitive Comparison of Doxa AB's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Doxa AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doxa AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Doxa AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Doxa AB's EV-to-EBIT falls into.



Doxa AB EV-to-EBIT Calculation

Doxa AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1554.010/9.3000000000001
=167.10

Doxa AB's current Enterprise Value is kr1,554.01 Mil.
Doxa AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doxa AB  (OSTO:DOXA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Doxa AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=9.3000000000001/1755.9808
=0.53 %

Doxa AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr1,755.98 Mil.
Doxa AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doxa AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Doxa AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Doxa AB (OSTO:DOXA) Business Description

Traded in Other Exchanges
Address
Axel Johanssons Gata 4-6, Uppsala, SWE, 754 50
Doxa AB is involved in developing, manufacturing and marketing bioceramic dental products in Sweden. It offers Ceramir Crown and Bridge, a dental cement used for the permanent fixture of dental crowns and bridges.

Doxa AB (OSTO:DOXA) Headlines

No Headlines